跳至主要内容
临床试验/NCT05618912
NCT05618912已完成不适用

Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: A Randomized Controlled Trial

Indiana University2 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2022年10月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
146
试验地点
2
主要终点
Cosmetic Outcome

研究概览

简要总结

Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing (Control) that will be covered with petrolatum jelly and bandaging during this time period, which has to be re-applied daily. Patients and dermatologic surgeons will then complete surveys 7 days, 30 days, and 90 days after surgery to evaluate the cosmetic appearance of these scars.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult > 18 years of age
  • Linear scars
  • Patients underwent conventional excision or Mohs micrographic surgery for primary cutaneous cancer or other cutaneous condition that required surgical intervention

排除标准

  • Scar localization on acral or hair bearing sites
  • Patients unable to converse in English
  • Patients requiring flap or graft for closure of wound
  • History of allergy to adhesives
  • Patient using topical chemotherapy agents on the surgical site or planning to start it within 3 months after surgery
  • Use of hydrocolloid dressings for post-operative wound care in the past

结局指标

主要结局

Cosmetic Outcome

时间窗: 90 days

Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.

次要结局

  • Number of Participants With Complications(7 days, 30 days, 90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Syril Keena Que

Assistant Professor of Clinical Dermatology

Indiana University

研究点 (2)

Loading locations...

相似试验